Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Preferred Stock Liabilities (2018 - 2021)

Entera Bio has reported Preferred Stock Liabilities over the past 4 years, most recently at $698000.0 for Q3 2021.

  • For the quarter ending Q3 2021, Preferred Stock Liabilities fell 54.82% year-over-year to $698000.0, compared with a TTM value of $698000.0 through Sep 2021, down 54.82%, and an annual FY2020 reading of $1.4 million, down 41.41% over the prior year.
  • Preferred Stock Liabilities came in at $698000.0 for Q3 2021, down from $1.4 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $8.5 million in Q1 2021 to a low of $578000.0 in Q2 2019.
  • Median Preferred Stock Liabilities over the past 4 years was $1.4 million (2020), compared with a mean of $2.1 million.
  • The sharpest move saw Preferred Stock Liabilities soared 306.57% in 2020, then tumbled 54.82% in 2021.
  • Over 4 years, Preferred Stock Liabilities stood at $1.4 million in 2018, then skyrocketed by 78.13% to $2.4 million in 2019, then plummeted by 41.41% to $1.4 million in 2020, then crashed by 51.26% to $698000.0 in 2021.
  • Per Business Quant, the three most recent readings for ENTX's Preferred Stock Liabilities are $698000.0 (Q3 2021), $1.4 million (Q2 2021), and $8.5 million (Q1 2021).